Basic Information
Opharmic is a platform company that develops ultrasonic technology to provide innovative solutions for patients and biopharmaceutical enterprises. Through more than a decade of research and technical development, the team has successfully developed drug delivery technologies for ocular surface, anterior segment, and retinal diseases in ophthalmic patients. With its patented non-invasive ultrasound technology, eye medications can be safely and effectively delivered into the eye, eliminating the need for repeated ocular injections. From technology and product customization to clinical development and regulatory strategies, Opharmic offers tailored technical and product solutions to pharmaceutical partners worldwide, enabling them to adopt exclusive cutting-edge technology in their newly developed or existing drugs.
--
Hong Kong,China
unclear
November 17, 2016
sarah.cheung@opharmic.com

